Risultati di ricerca
View Maurizio Voi’s profile on LinkedIn, a professional community of 1 billion members. I am currently Chief Medical Officer at Molecular Templates. I was previously Vice…
- 500+
- 1.4K
- University of Medicine
- Molecular Templates
8 nov 2011 · Pharma. Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer. Nov 8, 2011 7:20am. - Dr. Voi brings over 20 years of broad industry experience...
28 set 2023 · Dr. Voi possesses more than 35 years of wide-ranging drug development experience. Dr. Voi will begin his new role on October 2, 2023. Dr. Voi joins MTEM from Novartis, where he served as Vice...
- Molecular Templates, Inc.
28 set 2023 · September 28, 2023. Maurizio Voi. AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today announced the appointment of Dr. Maurizio Voi to the role of Chief ...
28 set 2023 · Dr. Voi possesses more than 35 years of wide-ranging drug development experience. Dr. Voi will begin his new role on October 2, 2023. Dr. Voi joins MTEM from Novartis, where he served as Vice President, Global Program Head, for the PD-1 antibody Tislelizumab since April 2021.
27 lug 2022 · Originario di Ragusa, il dottor Voi è esperto di tematiche di sviluppo di farmaci anti-tumorali e per il trattamento di tumori solidi, settori in cui vanta decine di pubblicazioni all’interno delle principali riviste scientifiche mondiali.
28 set 2023 · Dr. Voi will begin his new role on October 2, 2023. Dr. Voi joins MTEM from Novartis, where he served as Vice President, Global Program Head, for the PD-1 antibody Tislelizumab since April 2021.
